West Virginia Patent of the Month – December 2023
Omnia Medical, LLC is carving a niche in orthopedic implant technology, developing novel solutions to improve patient outcomes. The company has recently been granted a patent that redefines spinal implant technology. The patent provides a multi-material and multi-component intervertebral spacer aimed at improving osseointegration.
At the core of Omnia Medical’s innovation is a modular spinal implant system. This departure from conventional static implants introduces a new dimension of flexibility and customization. Surgeons can now tailor the implant to specific patient anatomy, adapting to the nuances of individual spinal structures.
The modular design allows for versatility in addressing various spinal conditions. Whether it’s degenerative disc disease, trauma, or other spinal disorders, this system provides a comprehensive solution. The ability to choose components based on patient needs not only enhances surgical precision but also streamlines the implantation process.
One standout feature is the emphasis on biomechanics. The implant system incorporates an anatomically contoured articulating surface, optimizing load distribution and minimizing stress on adjacent spinal segments. This focus on biomechanical functionality reflects a nuanced understanding of the intricacies of spinal dynamics.
Additionally, the patent details a novel screw blocking mechanism, enhancing the stability of the implant. Stability is a critical factor in spinal surgeries, and Omnia Medical’s approach demonstrates a commitment to achieving optimal outcomes for patients.
Beyond its technical aspects, the patent hints at a broader trend in medical innovation – a shift towards patient-centric solutions. By empowering surgeons with a customizable implant system, Omnia Medical is contributing to a future where medical interventions are increasingly tailored to individual patient needs.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
